Bo Yuan

11PUBLICATIONS
8CO-AUTHORS
Free radical chemistryCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 29, 2025
FAD012, a Ferulic Acid Derivative, Preserves Cerebral Blood Flow and Blood-Brain Barrier Integrity in the Rat Photothrombotic Stroke Model.

Hiroshi Sugoh, Hirokazu Matsuzaki, Jun Takayama

|Sep 27, 2025
CUD003, a Novel Curcumin Derivative, Ameliorates LPS-Induced Impairment of Endothelium-Dependent Relaxation and Vascular Inflammation in Mice.

Hirokazu Matsuzaki, Anna Arai, Meiyan Xuan

|Jul 29, 2025
Administration of Ascorbic Acid Alleviates Neuronal Damage After Cerebral Ischemia in ODS Rats.

Naohiro Iwata, Naoto Ogawa, Tom Imai

|Apr 17, 2025
Chronic Administration with FAD012 (3,5-Dimethyl-4-hydroxycinnamic Acid) Maintains Cerebral Blood Flow and Ameliorates Swallowing Dysfunction After Chronic Cerebral Hypoperfusion in Rats.

Takashi Asano, Hirokazu Matsuzaki, Meiyan Xuan

|Jan 08, 2025
Harnessing Arsenic Derivatives and Natural Agents for Enhanced Glioblastoma Therapy.

Bo Yuan, Hidetomo Kikuchi

|Jun 10, 2023
Involvement of the Restoration of Cerebral Blood Flow and Maintenance of eNOS Expression in the Prophylactic Protective Effect of the Novel Ferulic Acid Derivative FAD012 against Ischemia/Reperfusion Injuries in Rats.

Takashi Asano, Meiyan Xuan, Naohiro Iwata

Pageof 2

Frequent Collaborators

4 joint publications

Hirokazu Matsuzaki

3 joint publications

Hidetomo Kikuchi

1 joint publications

Shin-Ich Miyashita

1 joint publications

Kozo Yao